s'Arenal (ES)
{name}
{subtitle}
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~38 mi. (Cales de Mallorca, Spain, +89 more cities)
facility
Hospital Son Llatzer
biomarker
ER Positive, +1 more biomarker
condition
Breast Carcinoma
drug
giredestrant, +1 more drug
drug type
hormone therapy
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~38 mi. (Cales de Mallorca, Spain, +383 more cities)
facility
Hospital Son Llatzer
biomarker
ER Negative, +2 more biomarkers
condition
Breast Carcinoma
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~38 mi. (Cales de Mallorca, Spain, +122 more cities)
facility
Hospital Universitari Son Espases
condition
Prostate Adenocarcinoma
drug
radium Ra 223 dichloride
drug type
radiation therapy
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
city
~38 mi. (Cales de Mallorca, Spain, +81 more cities)
facility
Hospital Son Llatzer; Servicio de Oncologia
condition
Hepatocellular Carcinoma
drug
atezolizumab, +2 more drugs
drug type
immunotherapy, +1 more type
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~38 mi. (Cales de Mallorca, Spain, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
condition
Breast Carcinoma
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~38 mi. (Cales de Mallorca, Spain, +156 more cities)
facility
Hospital Universitari Son Espases /ID# 222889
biomarker
IGH-CCND1 Fusion, +1 more biomarker
condition
Multiple Myeloma
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type